My final earnings short-squeeze play toay is motion pictures player Imax (IMAX), which is set to release numbers on Thursday before the market open. This entertainment technology company specializes in motion picture technologies and large-format motion picture presentations. Wall Street analysts, on average, expect Imax to report revenue of $76.06 million on earnings of 21 cents per share.
On Monday, Hudson Square Research initiated coverage on Imax with a buy rating and a price target of $28 per share. Recent new movie releases like Dark Knight Rises, Resident Evil: Retribution, and The Amazing Spiderman, are expected to give a decent boost to revenue for the current quarter.The current short interest as a percentage of the float for Imax is extremely high at 23.9%. That means that out of the 55.34 million shares in the tradable float, 13.20 million shares are sold short by the bears. This is a very large short interest on a stock with a relatively low tradable float. If the bulls get the news they're looking for, then this stock could skyrocket higher post-earnings. From a technical perspective, IMAX is currently trading above its 50-day moving average and below its 200-day moving average, which is neutral trendwise. This stock has been uptrending slightly for the last two months, with shares rising from a low of $18.85 to its recent high of $22.46 a share. During that uptrend, shares of IMAX have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed IMAX within range of triggering a near-term breakout trade. If you're in the bull camp on IMAX, then I would wait until after its earnings report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $22.46 to $22.50 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 1 million shares. If we get that move, then IMAX will setup to re-test or possibly take out its next major overhead resistance levels at $23.95 to $25.99 a share post-earnings. I would simply avoid IMAX or look for short-biased trades if after earnings it fails to trigger that breakout, and then moves back below some key near-term support levels at $20.67 to $20.10 a share with high volume. If we get that move, then IMAX will setup to re-test or possibly take out its next major support levels at $18.85 to $18.29 a share. To see more potential earnings short squeeze plays, check out the Earnings Short Squeeze Plays portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV